在韩国患有心房的患者中,现实世界的阿皮克萨班度
Sun Hack Lee1, Mijin Kim1, Min Sun Kim1
1Department of Cardiology and Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, 179, Gudeok-Ro, Seo-Gu, Busan, 49241, Korea.
Blood research
|July 7, 2025
概括
血阿皮克萨班度 (PAC) 可能因心力衰竭等因素而变化. 监测PAC可能有助于为心房患者量身定制阿皮克萨班剂量,特别是那些心力衰竭患者的减少剂量,以提高安全性和疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 临床药房 临床药房
背景情况:
- 阿皮克萨班是一种用于心房的常见抗凝剂.
- 常规监测阿皮克萨班血度 (PAC) 并不是标准实践.
- 个人因素,如并发症,可以影响阿皮克萨班水平.
研究的目的:
- 在心房患者中分析PAC.
- 探索PAC和并发症是否提供了增强的风险分层.
- 调查影响阿皮克萨班水平的因素.
主要方法:
- 分析了49名接受阿皮克萨班治疗的心房动患者.
- 在服用后6小时内测量了XA因子水平.
- 与临床因素相关的PAC (年龄,体重,eGFR,心力衰竭,出血).
主要成果:
- 平均PAC为160.3 ng/mL. 这是一个很好的结果.
- 在每天两次服用5毫克的患者中观察到更高的PAC,而每天两次服用2.5毫克的患者则相比较高.
- 在降低剂量的患者中,功能和心力衰竭与PAC相关;与标准剂量PAC无关的因素.
结论:
- 根据年龄,体重和eGFR,阿皮克萨班的剂量通常是有效的.
- 降低剂量患者的心力衰竭可能会增加PAC和出血风险.
- 考虑到心力衰竭,调整阿皮克萨班处方可能会改善治疗结果.
相关概念视频
Time Course of Drug Effect
2.2K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.2K
Drug Concentrations: Measurements
576
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
576
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
888
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
888
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Drug Concentration Versus Time Correlation
1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K


